Literature DB >> 27208769

Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.

Marisa Holubar1, Lina Meng2, Stan Deresinski3.   

Abstract

This article reviews recent clinical evidence for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Vancomycin remains the initial antibiotic of choice for the treatment of patients with MRSA bacteremia and endocarditis due to isolates with vancomycin minimum inhibitory concentration ≤2 μg/mL, whereas daptomycin is an effective alternative, and ceftaroline seems promising. Treatment options for persistent MRSA bacteremia or bacteremia due to vancomycin-intermediate or vancomycin-resistant strains include daptomycin, ceftaroline, and combination therapies. There is a critical need for high-level evidence from clinical trials to allow optimally informed decisions in the treatment of MRSA bacteremia and endocarditis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteremia; Ceftaroline; Daptomycin; Endocarditis; MRSA; Methicillin; Staphylococcus aureus; Vancomycin

Mesh：

Substances：

Year:  2016        PMID： 27208769     DOI： 10.1016/j.idc.2016.02.009

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  10 in total

Review 1.  Infective endocarditis.

Authors:  Thomas L Holland; Larry M Baddour; Arnold S Bayer; Bruno Hoen; Jose M Miro; Vance G Fowler
Journal:  Nat Rev Dis Primers       Date:  2016-09-01       Impact factor: 52.329

2.  Competence Mining of Vancomycin (VAN) in the Management of Infections Due to Bacterial Strains With High VAN Minimum Inhibitory Concentrations (MICs): A Novel Dosing Strategy Based on Pharmacokinetic/Pharmacodynamic Modeling.

Authors:  Xiangqing Song; Meizi Zeng; Yi Wu; Yong Pan
Journal:  Front Microbiol       Date:  2021-04-22       Impact factor: 5.640

Review 3.  Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.

Authors:  Ali Hassoun; Peter K Linden; Bruce Friedman
Journal:  Crit Care       Date:  2017-08-14       Impact factor: 9.097

Review 4.  The Whole Price of Vancomycin: Toxicities, Troughs, and Time.

Authors:  Meghan N Jeffres
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

5.  Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin.

Authors:  Yael Koton; Zafrir Or; Naiel Bisharat
Journal:  Infect Dis Rep       Date:  2017-05-31

6.  Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.

Authors:  Preeti Pancholi; Karen C Carroll; Donna M Wolk; Blake W Buchan; Raymond C Chan; Neelam Dhiman; Bradley Ford; Paul A Granato; Amanda T Harrington; Diana R Hernandez; Romney M Humphries; Matthew R Jindra; Nathan A Ledeboer; Shelley A Miller; A Brian Mochon; Margie A Morgan; Robin Patel; Paul C Schreckenberger; Paul D Stamper; Patricia J Simner; Nancy E Tucci; Cynthia Zimmerman
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

7.  Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  Matthew Geriak; Fadi Haddad; Khulood Rizvi; Warren Rose; Ravina Kullar; Kerry LaPlante; Marie Yu; Logan Vasina; Krista Ouellette; Marcus Zervos; Victor Nizet; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

8.  Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.

Authors:  Zhouqi Li; Hemu Zhuang; Guannan Wang; Hui Wang; Ying Dong
Journal:  BMC Infect Dis       Date:  2021-01-14       Impact factor: 3.090

9.  Challenges in replicating secondary analysis of electronic health records data with multiple computable phenotypes: A case study on methicillin-resistant Staphylococcus aureus bacteremia infections.

Authors:  Inyoung Jun; Shannan N Rich; Zhaoyi Chen; Jiang Bian; Mattia Prosperi
Journal:  Int J Med Inform       Date:  2021-07-16       Impact factor: 4.730

10.  Cervicofacial Infections Caused by Staphylococcus aureus.

Authors:  Carlos Lazarte; Leonel Paladino; Luciana Mollo; Romina Katra; Brusca María Isabel; Sebastian Ariel Puia
Journal:  Ann Maxillofac Surg       Date:  2019 Jul-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.